Pharmadrug (TSE:PHRX) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
PharmaDrug Inc. has announced its subsidiary, SecureDose, has signed a Letter of Intent with a Canadian licensed dealer to manufacture and distribute biosynthetic pharmaceutical grade cocaine, aiming to contribute to harm reduction through safe supply programs. The company is advancing towards a full agreement post technology transfer and commercial-scale process application, with potential global distribution and revenue opportunities.
For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.